Sur vs Turkmenistan: Measles-containing-vaccine second-dose (MCV2) immunization coverage
Sur
52.0%
in 2025
Turkmenistan
99.0%
in 2025
Sur rank
1st
Turkmenistan rank
1st
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Sur
- Turkmenistan
How they compare
Turkmenistan currently reports 99.0% against 52.0% in Sur, a difference of 47.0%.
That makes Turkmenistan's figure about 1.9 times Sur's.
Across all 26 years both countries report, Turkmenistan has been ahead every year.
Sur ranks 1st and Turkmenistan ranks 1st of 1 regions.
Turkmenistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Sur | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 94.5% | 94.5% | Turkmenistan |
| 2010s | 18.0% | 99.0% | 81.0% | Turkmenistan |
| 2020s | 45.7% | 98.8% | 53.2% | Turkmenistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Sur or Turkmenistan?
- Turkmenistan, at 99.0% against 52.0% in Sur as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Sur and Turkmenistan?
- 47.0%, with Turkmenistan ahead.
- How many years of comparable data are there for Sur and Turkmenistan?
- 26 years are reported by both, from 2000 to 2025.
- How do Sur and Turkmenistan rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Sur ranks 1st and Turkmenistan ranks 1st of 1 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.